Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanyan Lou

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Chinese Clinical Oncology|June 25, 2023
When not having a tissue may not be an issue in advanced lung cancerShenduo Li, Yanyan Lou, Rami Manochakian
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2025
Osimertinib and Cardiotoxicity: A Topic to Keep AddressingShenduo Li, Rami Manochakian, Yujie Zhao, et al.
Journal of Hematology & Oncology|December 13, 2016
Emerging therapeutic agents for lung cancerBhagirathbhai Dholaria, William Hammond, Amanda Shreders, et al.
Journal of Hematology & Oncology|July 9, 2021
Targeted therapy in advanced non-small cell lung cancer: current advances and future trendsUmair Majeed, Rami Manochakian, Yujie Zhao, et al.
Journal of Hematology & Oncology|March 20, 2021
Next generation of immune checkpoint inhibitors and beyondJulian A Marin-Acevedo, ErinMarie O Kimbrough, Yanyan Lou
Chinese Clinical Oncology|August 21, 2024
Befotertinib: one more drug targeting EGFR-the more may be the merrierGuilherme Sacchi de Camargo Correia, Yanyan Lou, Rami Manochakian
SAGE Open Medical Case Reports|November 5, 2020
Patients with high-grade alectinib-induced skin rash: How do we desensitize these patients? A case report and review of literatureKaran Seegobin, Umair Majeed, Yanyan Lou, et al.
Oncotargets and Therapy|May 23, 2019
ZNF277 regulates ovarian cancer cell proliferation and invasion through inhibition of PTENZhengling Liu, Zonglan Xu, Yonghui Tian, et al.
Optics Express|June 6, 2009
CVD diamond alpha-particle detectors with different electrode geometryLinjun Wang, Yanyan Lou, Qingfeng Su, et al.
Exploration of Targeted Anti-Tumor Therapy|January 7, 2025
Curative immunotherapy-based strategies for non-metastatic non-small cell lung cancerJustin J Kuhlman, Shenduo Li, Rami Manochakian, et al.
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Chinese Clinical Oncology|June 25, 2023
When not having a tissue may not be an issue in advanced lung cancerShenduo Li, Yanyan Lou, Rami Manochakian
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2025
Osimertinib and Cardiotoxicity: A Topic to Keep AddressingShenduo Li, Rami Manochakian, Yujie Zhao, et al.
Journal of Hematology & Oncology|December 13, 2016
Emerging therapeutic agents for lung cancerBhagirathbhai Dholaria, William Hammond, Amanda Shreders, et al.
Journal of Hematology & Oncology|July 9, 2021
Targeted therapy in advanced non-small cell lung cancer: current advances and future trendsUmair Majeed, Rami Manochakian, Yujie Zhao, et al.
Journal of Hematology & Oncology|March 20, 2021
Next generation of immune checkpoint inhibitors and beyondJulian A Marin-Acevedo, ErinMarie O Kimbrough, Yanyan Lou
Chinese Clinical Oncology|August 21, 2024
Befotertinib: one more drug targeting EGFR-the more may be the merrierGuilherme Sacchi de Camargo Correia, Yanyan Lou, Rami Manochakian
SAGE Open Medical Case Reports|November 5, 2020
Patients with high-grade alectinib-induced skin rash: How do we desensitize these patients? A case report and review of literatureKaran Seegobin, Umair Majeed, Yanyan Lou, et al.
Oncotargets and Therapy|May 23, 2019
ZNF277 regulates ovarian cancer cell proliferation and invasion through inhibition of PTENZhengling Liu, Zonglan Xu, Yonghui Tian, et al.
Optics Express|June 6, 2009
CVD diamond alpha-particle detectors with different electrode geometryLinjun Wang, Yanyan Lou, Qingfeng Su, et al.
Exploration of Targeted Anti-Tumor Therapy|January 7, 2025
Curative immunotherapy-based strategies for non-metastatic non-small cell lung cancerJustin J Kuhlman, Shenduo Li, Rami Manochakian, et al.
Pageof 12